Selecting optimal therapy in the evolving therapeutic landscape of metastatic pheochromocytoma and paraganglioma.

Hamoud M, Samperio VM, Ghonge A, Tomanec A, Dasanu CA

Open source

DOI
10.1080/14656566.2026.2704873
Published
2026 Aug
Container
Expert opinion on pharmacotherapy
Publisher
Not recorded
Open access
no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1080/14656566.2026.2704873,
  title = {Selecting optimal therapy in the evolving therapeutic landscape of metastatic pheochromocytoma and paraganglioma.},
  author = {Hamoud M and Samperio VM and Ghonge A and Tomanec A and Dasanu CA},
  year = {2026},
  journal = {Expert opinion on pharmacotherapy},
  doi = {10.1080/14656566.2026.2704873},
  url = {https://doi.org/10.1080/14656566.2026.2704873}
}

RIS

TY  - JOUR
TI  - Selecting optimal therapy in the evolving therapeutic landscape of metastatic pheochromocytoma and paraganglioma.
AU  - Hamoud M
AU  - Samperio VM
AU  - Ghonge A
AU  - Tomanec A
AU  - Dasanu CA
PY  - 2026
JO  - Expert opinion on pharmacotherapy
DO  - 10.1080/14656566.2026.2704873
UR  - https://doi.org/10.1080/14656566.2026.2704873
ER  - 

APA

M, H., VM, S., A, G., A, T., & CA, D. (2026). Selecting optimal therapy in the evolving therapeutic landscape of metastatic pheochromocytoma and paraganglioma.. Expert opinion on pharmacotherapy. https://doi.org/10.1080/14656566.2026.2704873

Source records